Driehaus Capital Management LLC Moderna, Inc. Transaction History

Driehaus Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $4.47 Million - $7.29 Million	-19,776 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $3.67 Million - $8.02 Million	16,555 Added 513.97%	19,776 $7.61 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $136,665 - $247,198	1,052 Added 48.5%	3,221 $757,000
Q1 2021 May 17, 2021	BUY	$109.18 - $185.98 $17,905 - $30,500	164 Added 8.18%	2,169 $284,000
Q4 2020 Feb 16, 2021	SELL	$65.74 - $169.86 $116,557 - $301,161	-1,773 Reduced 46.93%	2,005 $209,000
Q3 2020 Nov 16, 2020	BUY	$54.34 - $94.85 $25,105 - $43,820	462 Added 13.93%	3,778 $267,000
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $98,385 - $265,280	3,316 New	3,316 $213,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.